Chemotherapy resistance contributes to poor outcomes in gastric cancer (GC), and overexpressed ITGA2 has been observed in chemotherapy-resistant cells, suggesting a role in mediating resistance. This evidence concerns the gene ITGA2 and gastric cancer.